SlidesetHIVINTEREST 2016(Abstract) Quality of life among HIV/AIDS patients on anti retro-viral therapy at Letlhakane primary hospital (Botswana): a cross sectional study | L. KumbonekiView Slideset
SlidesetHIVINTEREST 2016(Abstract) Current profile of dermatological diseases and events during HIV in Dakar | N.M.DiaView Slideset
SlidesetHIVINTEREST 2016(Abstract) Prevalence of non-infectious co-morbidities among HIV-positive subjects stably treated with tenofovir, lamivudine and ritonavir-boosted lopinavir in Cameroon | D. Fokom VictoireView Slideset
SlidesetHIVINTEREST 2016Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Isaac TitaView Slideset
SlidesetHIVINTEREST 2016Formal Debate: Resolved that 90-90-90 Cannot be Attained | Opposing the motion | Badara Samb, MD, PhDView Slideset
SlidesetHIVINTEREST 2016(Abstract) Ultra-deep pyrosequencing of paediatric HIV-1 drug resistance and coreceptor suggests possible suitability of protease inhibitors and maraviroc at younger ages in Cameroon | J. FokamView Slideset
MSMauro SchechterMD, PhDSlidesetHIVINTEREST 2016Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Mauro Schechter, MD, PhDView Slideset
VMVictor MusiimeMBChB, MMed, PhDSlidesetHIVINTEREST 201690-90-90 for all - Scale up of HIV Treatment for Adolescents | Victor Musiime, MBChB, MMED, PhDView Slideset
SlidesetHIVINTEREST 2016Transmitted Drug Resistance and First-line ART Treatment Outcomes in Ugandan Children | H. MugerwaView Slideset
SlidesetHIVINTEREST 2016(Abstract) Favourable outcomes of paediatric second-line protease inhibitor-based antiretroviral treatment in Uganda | R.S. BoermaView Slideset
SlidesetHIVINTEREST 2016(Abstract) Decline in positivity rates among HIV-exposed infants with changes in PMTCT ARV regimens in Nigeria: evidence from 7 years of field implementation | H. KhamofuView Slideset
SlidesetHIVINTEREST 2016Supporting Beyond Treatment - Care for HIV Positive Adolescents | Rama DiagneView Slideset
